Does Bristol Myers have a patient assistance program?

Bristol-Myers Squibb Company (BMS) established the Bristol-Myers Squibb Patient Assistance Foundation, Inc. (BMSPAF) to help patients who need help paying for medicines prescribed by their healthcare providers.

Will there be a generic for Eliquis in 2021?

The FDA recently approved the first-ever generic versions of Eliquis (apixaban), a medication that helps prevent stroke, blood clots, and embolisms. The generics will offer lower-cost alternatives for people who struggle to afford brand-name Eliquis.

What if I cant afford my Eliquis?

Call Tap to call 1-855-ELIQUIS (354-7847) from Monday – Friday, 8 AM – 8 PM (ET). Live specialists are here to: Help you find out if ELIQUIS is covered by your insurance plan. Determine if you are eligible for assistance paying for ELIQUIS.

What does Bristol Myers Squibb do?

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. At Bristol Myers Squibb, we believe in the power of science to address some of the most challenging diseases of our time.

When did Bristol-Myers Squibb go public?

1933
In 1929 Bristol-Myers was absorbed by a giant holding company, Drug Inc., which, however, dissolved during the Great Depression. Bristol-Myers became a publicly traded company in 1933.

What is the Bristol Myers Squibb Patient Assistance Foundation?

What is the Bristol Myers Squibb Patient Assistance Foundation? The Bristol Myers Squibb Patient Assistance Foundation (BMSPAF) is an independent, charitable organization that helps eligible patients who need temporary help obtaining the medicines listed on this website.

Do you have a complaint about a Bristol Myers Squibb product?

If you, or someone you know, have possibly experienced a side effect or have a product complaint while taking a Bristol Myers Squibb product, please contact us. As of 2019, Bristol Myers Squibb and Celgene have merged.

What drugs are covered by the Bristol Myers Squibb Foundation?

ELIQUIS® (apixaban) EMPLICITI ® (elotuzumab) NULOJIX ® (belatacept) ONUREG® (azactidine) tablets OPDIVO® (nivolumab) ORENCIA® (abatacept) SPRYCEL® (dasatinib) YERVOY ® (ipilimumab) ZEPOSIA® (ozanimod) The Bristol Myers Squibb Patient Assistance Foundation (BMSPAF) does not charge a fee for participation in BMSPAF.

Are there translators available for Bristol Myers Squibb products?

Translators are available in many languages. If you have been prescribed a BMS medication, contact your BMS patient program representative to learn more. If you, or someone you know, have possibly experienced a side effect or have a product complaint while taking a Bristol Myers Squibb product, please contact us.